# OnCo record lymphoma-tx-car-t-pathway (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/lymphoma-tx-car-t-pathway/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "lymphoma-tx-car-t-pathway" ;
  schema:name "The CAR-T pathway in lymphoma: referral, apheresis, bridging and the waiting"@en ;
  schema:alternateName "CAR-T referral lymphoma"@en, "Bridging therapy"@en, "Leukapheresis for CAR-T"@en, "Vein-to-vein time"@en ;
  schema:description "CAR-T is not a prescription but a manufacturing process. Cells are collected from the patient, sent away to be engineered, and returned three to five weeks later. What happens during that wait decides whether the treatment is given at all."@en ;
  schema:url <https://onco.cc/terms/lymphoma-tx-car-t-pathway/> ;
  schema:dateModified "2026-09-29"^^xsd:date ;
  schema:citation <https://doi.org/10.1182/blood.2022018730> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/mantle-cell-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/primary-mediastinal-b-cell-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/apheresis-starting-material/>, <https://onco.cc/technologies/car-t-manufacturing-process/> ;
  onco:drugs <https://onco.cc/drugs/axicabtagene-ciloleucel/>, <https://onco.cc/drugs/lisocabtagene-maraleucel/>, <https://onco.cc/drugs/tisagenlecleucel/>, <https://onco.cc/drugs/brexucabtagene-autoleucel/>, <https://onco.cc/drugs/fludarabine/>, <https://onco.cc/drugs/cyclophosphamide/> ;
  onco:terms <https://onco.cc/terms/lymphodepletion/>, <https://onco.cc/terms/lymphoma-tx-crs-icans/>, <https://onco.cc/terms/lymphoma-tx-immunoglobulin-replacement/> ;
  onco:trials <https://onco.cc/trials/zuma-7/>, <https://onco.cc/trials/transform/>, <https://onco.cc/trials/belinda/> .